Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
EGFR BATs by Transtarget for Gliosarcoma: Likelihood of Approval
EGFR BATs is under clinical development by Transtarget and currently in Phase I for Gliosarcoma. According to GlobalData, Phase I...
Data Insights
EGFR BATs by Transtarget for Glioblastoma Multiforme (GBM): Likelihood of Approval
EGFR BATs is under clinical development by Transtarget and currently in Phase I for Glioblastoma Multiforme (GBM). According to GlobalData,...